发明名称 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease
摘要 A compound of Formula (I), and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: wherein R1 is independently selected from F, CI, Br, CN, NH2, OH, CHO, COOH, oxo, C1-4alkyl, C1-4alkoxy, CONH2 (optionally mono- or di-substituted by C1-4alkyl) and SO2NH2, R2 is independently selected from C1-6allkyl substituted by R3 wherein the C1-6alkyl chain optionally comprises one or two heteroatoms select from O; R3 is selected from aryl, C3-6cycloalkyl, C3-6heterocyclyl and C3-6heteroaryl, wherein the heterocyclyl and heteroaryl rings are nitrogen containing; and wherein R3 is optonally substituted by one or more groups selected from R1; n1 is zero or an integer from 1 to 2; n2 is an integer from 1 to 2; and the sum of n1 and 2 is less than or equal to 2; R5 is selected from any group defined for R1 and R2; R6a and R6b are independently selected from H or C1-4alkyl; R7 is independently selected from F, CI, Br, CN, NH2, OH, CHO, COOH, oxo, C1-4alkyl, C1-4alkoxy, CONH2 (optionally mono- or di-substituted by C1-4alkyl) and SO2NH2, Q1, Q2 and Q3 are independently selected from H or any group defined for R1 and R2; or Q1 and Q2 or Q2 and Q3 together form a C5-6heteroaryl or C5-6heterocylclic ring; optionally containing one or two heteroatoms selected from N and O optionally substituted by any group selected from R5; Z is selected from linear C2-3 alkylene; X3 is O; X4 is selected from aryl, a 9-10 membered heteroaryl ring or a 9-10 membered heterocyclic ring, wherein the heteroaryl and heterocyclic rings contain one or more heteroatoms selected from N, and optionally additionally O, and wherein X4 is optionally substituted by one or two oxo moieties and is optionally substituted by one or more groups selected from R7; with the proviso that: (i) when X4 is phenyl then Q1 and Q2 or Q2 and Q3-together form an optionally substituted heteroaryl or heterocylclic ring as defined above; and (ii) when Q1, Q2 and Q3 are independently selected from H or any group defined for R1 and R2 then X4 is not phenyl except when R2 is C1-5alkyl substituted by R3 wherein R3 is C3-6heterocyclyl as defined above.
申请公布号 GB2502226(A) 申请公布日期 2013.11.20
申请号 GB20130015409 申请日期 2012.02.06
申请人 UNIVERSITY OF NOTTINGHAM 发明人 JILLIAN G BAKER;PETER M FISCHER;CHRISOPHE FROMONT;SHEILIA M GARDINER;STEPHEN J HILL;GOPAL JADHAV;BARRIE KELLAM;SHAILESH MISTRY;JEANETTE WOOLARD
分类号 C07D209/46;A61K31/357;A61K31/4035;A61K31/445;A61K31/4725;A61K31/498;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/06;C07C217/54;C07D211/38;C07D215/20;C07D217/24;C07D309/06;C07D319/20;C07D405/12;C07D405/14 主分类号 C07D209/46
代理机构 代理人
主权项
地址
您可能感兴趣的专利